CLINICAL_TRIALS
trial_result
· 2025-01-08
Clinical Trial Update: Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept [Phase 2]
Summary
Phase 2 trial completed to develop a normative imaging database for rheumatoid arthritis using Tc99m tilmanocept; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Navidea Biopharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2025-01-08